Philippine News Agency
DOH acts ‘with urgency’ to get vaccine deal with Pfizer
The Department of Health (DOH) has defended its timeline for securing COVID-19 vaccines from Pfizer, refuting claims that the government missed an opportunity for an earlier acquisition.
Health Secretary Francisco Duque III stated that the DOH acted with urgency and followed government protocols throughout the negotiations with Pfizer.
Duque clarified that negotiations were ongoing and that Secretary Galvez signed a Confidentiality Data Agreement (CDA) with Pfizer in November.
These statements were in response to accusations by Foreign Secretary Teodoro Locsin Jr. that an earlier deal for 10 million Pfizer vaccine doses, with potential January 2021 delivery, fell through due to negligence.
Topics in this story
Explore more stories about these topics.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.
President Rodrigo Duterte saw "no major lapse" in the country's negotiations with Pfizer for COVID-19 vaccines, with Malacañang stating that the ongoing talks mean it is not a major issue.
+1
Read more →
Health Undersecretary Maria Rosario Vergeire clarified that the Confidentiality Disclosure Agreement (CDA) between the Philippine government and Pfizer did not guarantee a supply of COVID-19 vaccines.
Read more →
Health Secretary Francisco Duque III defended himself against accusations that he delayed the Philippines' early access to the Pfizer COVID-19 vaccine.
Read more →
Most procurement agreements for COVID-19 vaccines are expected to be signed by January 2021, according to vaccine czar Carlito Galvez Jr.
Read more →
The Philippines missed an opportunity to secure approximately 10 million doses of the Pfizer-BioNTech COVID-19 vaccine for early delivery in January 2021 due to a delayed submission of a Confidentiality Disclosure Agreement.
Read more →